RNA, U6 small nuclear 732, pseudogene (RNU6-732P)

RNU6-732P (RNA, U6 small nuclear 732, pseudogene) is a human pseudogene derived from the U6 small nuclear RNA (U6 snRNA) gene family, specifically reflecting a non-functional, transcriptionally inactive or regulatory RNA segment within the genome[4][5]. The canonical U6 snRNA is a core component of the spliceosomal complex responsible for pre-mRNA splicing in eukaryotes and is highly conserved and essential for RNA splicing[1][3]. Pseudogenes like RNU6-732P typically represent evolutionary remnants that share sequence homology with functional counterparts but lack the capability to encode an active RNA or protein. Although some pseudogenes may occasionally be transcribed and act as regulatory RNA molecules (for example, by acting as miRNA decoys or antisense regulators), there is no direct evidence that RNU6-732P has any known functional or therapeutic relevance in human disease, nor is it considered a receptor, enzyme, or established drug target[2]. Novel U6 RNA pseudogenes, including structures like RNU6-732P, are characterized by partial sequence homology, insertions, deletions, or duplications, and may provide insight into genome evolution but do not encode a functional product[4][5]. Notes: - This entry is not considered a therapeutic target and is not druggable. - As a pseudogene and not an active small nuclear RNA, it is not suited for "target" annotation in pharmacological or therapeutic databases[2][3]. - There is nothing obviously misspelled, but the designation is not a druggable or functionally annotated biomolecule. Summary of why `is_incorrect: true`: RNU6-732P represents a pseudogene and is not a canonical biological or therapeutic target (e.g., not a receptor, enzyme, transporter, or recognized regulator), has no known drugs, mechanisms, biomarkers, or safety considerations and thus does not fit the definition required for a pharmaceutical “target” entry[2][3][4][5].

Other names

RNU6-732PU6 snRNA pseudogeneU6 small nuclear RNA pseudogene